CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −377 | $458.74 | $173K | 7,063 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −268 | $459.86 | $123K | 6,795 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −271 | $461.12 | $125K | 6,524 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,322 | $463.26 | $612K | 5,202 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,225 | $464.06 | $568K | 3,977 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −966 | $465.11 | $449K | 3,011 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −568 | $466.06 | $265K | 2,443 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −321 | $467.09 | $150K | 2,122 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,573 | $468.12 | $736K | 549 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −451 | $469.18 | $212K | 98 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −84 | $470.37 | $40K | 14 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14 | $470.76 | $7K | 0 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 36,565 | ||
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | −14,625 | $117.76 | $1.7M | 14,625 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −116 | $456.87 | $53K | 14,509 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −692 | $457.92 | $317K | 13,817 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −700 | $458.74 | $321K | 13,117 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −498 | $459.87 | $229K | 12,619 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −503 | $461.12 | $232K | 12,116 |
| 2026-01-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,456 | $463.26 | $1.1M | 9,660 |
Page 160 of 171 · 3,408 trades